Explore 3 Stock Ideas & Industry Insights Download Free Report

News

FMR LLC Reports 13.5% Stake in MiniMed Group

FMR LLC and Abigail P. Johnson filed a Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of 37,861,566 shares of common stock in MiniMed Group Inc., representing 13.5% of the class, as of an event date of October 30, 2026.

Nitish Kishor | 06 November 2026

FMR LLC Reports 11.2% Stake in Aspen Neuroscience

FMR LLC and Abigail P. Johnson filed a Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of 3,250,000 shares of Aspen Neuroscience Inc. common stock as of October 30, 2026.

Shwetambri Chauhan | 06 November 2026

FMR LLC Reports 15.0% Stake in Tango Therapeutics

FMR LLC filed an amended Schedule 13G with the SEC on November 5, 2026, disclosing a 15.0% beneficial ownership position in Tango Therapeutics Inc. common stock as of October 30, 2026.

Aakashdeep | 06 November 2026

FMR LLC Reports 8.1% Stake in Strive Inc Class A Stock

FMR LLC and Abigail P. Johnson filed Amendment No. 2 to Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of 9,514,519 shares of Strive Inc Class A Common Stock as of October 30, 2026.

Aditi Sarkar | 06 November 2026

FMR LLC Reports 9.1% Stake in Sprouts Farmers Market

FMR LLC and Abigail P. Johnson filed Amendment No. 4 to their Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of common stock in Sprouts Farmers Market Inc. as of October 30, 2026.

Manish Choudhary | 06 November 2026

FMR LLC Reports 14.0% Stake in City Therapeutics

FMR LLC and Abigail P. Johnson filed a Schedule 13G with the SEC on November 6, 2026, disclosing beneficial ownership of common stock in City Therapeutics Inc. as of October 30, 2026.

Vinay Lochav | 06 November 2026

FMR LLC Reports 6.9% Stake in Upstream Bio Inc

FMR LLC and Abigail P. Johnson filed Amendment No. 3 to a Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of common stock in Upstream Bio Inc as of October 30, 2026.

Manish Choudhary | 06 November 2026

Iron Mountain CEO Meaney Plans Sale of 38,474 Shares

Iron Mountain Inc. officer and director William L. Meaney filed a Form 144 notice of proposed sale on November 6, 2026, covering 38,474 shares of Iron Mountain common stock acquired through a stock option exercise.

Manish Choudhary | 06 November 2026

Sue Gove Buys 9,795 LKQ Shares at $20.5294

Director Sue Gove filed a Form 4 with the SEC on November 6, 2026, disclosing a purchase of LKQ Corp common stock on November 4, 2026.

Aakashdeep | 06 November 2026

Davis Selected Advisers Reports 6.7% Stake in JBS N.V.

Davis Selected Advisers filed an amended Schedule 13G with the SEC on November 6, 2026, disclosing beneficial ownership of 52,234,136 shares of JBS N.V. common stock as of September 30, 2026.

Vinay Lochav | 06 November 2026
Support

Hi! How can we help you today?

Loading…